# Infliximab Therapy in Patients With Refractory Polymyalgia Rheumatica

> **NCT01423591** · PHASE3 · UNKNOWN · sponsor: **Hospital Universitario Marqués de Valdecilla** · enrollment: 23 (actual)

## Conditions studied

- Polymyalgia Rheumatica

## Interventions

- **DRUG:** infliximab
- **DRUG:** inactive powder

## Key facts

- **NCT ID:** NCT01423591
- **Lead sponsor:** Hospital Universitario Marqués de Valdecilla
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-06
- **Primary completion:** 2010-09
- **Final completion:** 2011-12
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2011-08-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01423591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01423591, "Infliximab Therapy in Patients With Refractory Polymyalgia Rheumatica". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01423591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*